Mike Liao
Vice President, Clinical Pharmacology Third Arc Bio
Seminars
Wednesday 19th November 2025
speakers
9:45 am
Thursday 20th November 2025
Panel Discussion: Reflections From Drug Developers: What Worked When Applying MIDD, What Didn’t & Why?
1:00 pm
- Hear firsthand experiences on how MIDD strategies have successfully expedited clinical and regulatory milestones
- Explore common challenges and resistance factors that limited MIDD adoption, with advice on overcoming these obstacles
- Analyze retrospective case studies to identify best practices and lessons learned from embedding MIDD more effectively across development teams
Wednesday 19th November 2025
Chair’s Closing Remarks
5:30 pm
Wednesday 19th November 2025
Chair’s Opening Remarks
8:55 am
Wednesday 19th November 2025
Accelerating Clinical Trial Entry: Tailoring Modality-Specific- MIDD Strategies for Maximum Efficiency in ADC & TCE trials
12:00 pm
- Hear advice on designing modality-specific approaches where strategic plans were uniquely differed for contrasting modalities
- Learn the type of in vitro and in vivo data required for translational modeling for FIH dose selection for ADCs and TCEs
- Gain insights from case studies where this tailoring approach has enabled acceleration of clinical trials
